Plain-English translation of NCT05672836 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a new medication called to see if it can help prevent serious heart complications in patients who have had transcatheter aortic valve replacement (a minimally invasive surgery to fix a narrow aortic valve) and who also have heart failure with preserved ejection fraction (a condition where the heart doesn't relax properly). Researchers will compare this medication to a placebo (a dummy pill with no active ingredient) to see if the treatment reduces heart attacks, strokes, and hospitalizations for heart failure.
After valve replacement surgery, some patients continue to have heart failure symptoms and are at risk for serious complications. This medication has shown promise in helping hearts work better, and researchers want to know whether adding it to standard care can prevent these serious events.
You likely qualify if…
You likely don't qualify if…
You would take one tablet of the medication (or placebo) once daily at home, along with your regular heart medications. You would visit the study center at regular intervals for follow-up visits, where doctors will check your heart function, blood pressure, and how you are feeling. The study will follow you for an extended period to see whether the medication helps reduce serious heart events or hospitalizations compared to placebo.
AI-generated summary from trial data · Aug 12, 2026 · Not medical advice
South Korea